AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 249: H1134-H1142, 1985;
0363-6135/85 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berg, T.
Right arrow Articles by Nustad, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berg, T.
Right arrow Articles by Nustad, K.

AJP - Heart and Circulatory Physiology, Vol 249, Issue 6 1134-H1142, Copyright © 1985 by American Physiological Society


ARTICLES

Enzymatic activity of rat submandibular gland kallikrein released into blood

T. Berg, L. Johansen and K. Nustad

Enzymatic activity of submandibular gland (SG) kallikrein released into saliva and blood was studied at rest and after autonomic nerve stimulation. Kallikrein was measured by an immunometric assay that allows measurement of immunoreactive kallikrein in complex with inhibitors as well as simultaneous determination of kallikrein enzymatic activity. Measurements using the chromogenic substrate S2266 gave identical results to the natural substrate kininogen. Endogenous SG kallikrein secretory rate was, at rest, 0.9 +/- 0.1 ng/min. Kallikrein secretion into blood in response to autonomic nerve stimulation paralleled that into saliva, and secretion was greatly enhanced by alpha-adrenergic stimulation. In plasma, kallikrein was bound to several inhibitors that completely or partially blocked the enzyme activity. In arterial and SG venous control plasma, 93 +/- 3 and 72 +/- 10% inhibition of kallikrein enzyme activity was observed, respectively. Sympathetic stimulation after administration of a beta-adrenergic blocker increased kallikrein enzyme activity 62 and 11 times in arterial and SG venous plasma, respectively, with a corresponding 78 +/- 8 and 70 +/- 8% inhibition of kallikrein enzyme activity. A fraction containing kallikrein resembling "free kallikrein" was always present in plasma.


This article has been cited by other articles:


Home page
HypertensionHome page
J. Chao, H. Yin, L. Gao, M. Hagiwara, B. Shen, Z.-R. Yang, and L. Chao
Tissue Kallikrein Elicits Cardioprotection by Direct Kinin B2 Receptor Activation Independent of Kinin Formation
Hypertension, October 1, 2008; 52(4): 715 - 720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online